Hyderabad, India, March 09, 2018 --(PR.com
)-- Pharmascroll, a Market Research and Consulting firm registered and launched in June 2017, has been a renowned Syndicated research provider in Pharmaceutical space. Pharmascroll has generated over 30 market research reports in multiple disease indications including Secondary Progressive Multiple Sclerosis, Primary Progressive Multiple Sclerosis and Migraine disease indications in less than a year of the launch of company. The reports generated by the company are extensive covering the disease insights, etiology, epidemiology along with forecast, pipeline and current drugs overview including Forecasts for 15 years for a disease indication.
In addition to the Syndicated Research Business, Pharmascroll has now announced entry into the Customized Market Research Business in Pharmaceutical domain. The company plans to offer customized research for the companies and partners based on their requirements and business needs in the following broad areas- Understanding disease overview, Disease epidemiology, Drugs and market overview, Drug pipeline review, Drug Attribute analysis, Market Forecasts, Competitive Intelligence information, Monthly/Quarterly research reports/newsletter updates, understanding physician and customer insights based on publicly available data.
“Pharmascroll has gained success in the Syndicated Research Business in a very short span of time. We have thousands of followers including physicians, patients and pharma company representatives on our social media pages including LinkedIn and twitter. This displays the confidence of our prospective customers in our Research and Analytics abilities. Backed by the strength of success of our Syndicated Research Business, we would now like to offer Customized Market Research services to Pharmaceutical firms including other Pharma Market Research firms to better cater to their needs and help the patients in getting better treatments and information in longer term,” said, Bhawna Gupta, Director, Pharmascroll.
Pharmascroll is a diligent business consulting and market research firm focused solely towards pharmaceutical markets. The company consults and researches in majorly chronic disease indications prevalent across the globe. The research conducted by Pharmascroll analysts is targeted to provide analytical and logical answers to the key business questions of the pharmaceutical and medical insights teams and to make better informed business decisions with the detailed relevant information available.